Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Recall strategies for the verbal fluency test in patients with multiple sclerosis.
Increased expression of Aquaporin 4 in the rat hippocampus and cortex during trimethyltin-induced neurodegeneration.
Explaining, not just predicting, drives interest in personal genomics.
Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.
BAX inhibitor-1 is a Ca(2+) channel critically important for immune cell function and survival.
The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells.
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity.
Fostering adherence to injectable disease-modifying therapies in multiple sclerosis.
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials.
Validity of Minimal Clinically Important Difference Values for the Multiple Sclerosis Walking Scale-12?
Altered resting-state functional connectivity in cognitively preserved pediatric-onset MS patients and relationship to structural damage and cognitive performance.
Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
Epigenetics in autoimmune diseases: Pathogenesis and prospects for therapy.
Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?
Quality of life in Polish patients with multiple sclerosis.
Does Infection-Induced Immune Activation Contribute to Dementia?
Neuropsychological Performance, Brain Imaging, and Driving Violations in Multiple Sclerosis.
Clinical response to interferon beta and glatiramer acetate in multiple sclerosis patients: a Brazilian cohort.
Novel Targets in Multiple Sclerosis: to Oxidative Stress and Beyond.
The role of antiproliferative gene Tob1 in the immune system.
Glutamate Release Machinery Is Altered in the Frontal Cortex of Rats with Experimental Autoimmune Encephalomyelitis.
[Every fifth case of multiple sclerosis is familial.]
[Relationship between biochemical parameters of cerebrospinal fluid and the course of multiple sclerosis.]
Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod.
Neuropathology of multiple system atrophy: New thoughts about pathogenesis.
Pages
« first
‹ previous
…
454
455
456
457
458
459
460
461
462
…
next ›
last »